The overall market for chronic pain therapies is predicted to remain stable at approximately $20 billion. Chronic back pain and arthritis pain together account for nearly 57 percent of the overall chronic pain drug market in 2010. The report also found pain physicians are skeptical the government-mandated Risk Evaluation and Mitigation Strategy programs will change physician prescribing habits.
Related Articles on Pain Management:
Dr. Andrew C. Charles Named First Luskin Chair in Migraine and Headache Studies at UCLA
DSM Collaborates with AdeTherapeutics to Develop Pain Management and Scar
Reduction Product for Spine Surgeries
Neuros Medical Receives Approval for Pilot Study of Electrical Nerve Block Technology
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
